nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—GNMT—prostate cancer	0.569	1	CbGaD
Glycine—ALAS2—prostate gland—prostate cancer	0.00339	0.03	CbGeAlD
Glycine—GLYATL1—renal system—prostate cancer	0.00324	0.0287	CbGeAlD
Glycine—AGXT—prostate gland—prostate cancer	0.00306	0.0272	CbGeAlD
Glycine—GLYAT—renal system—prostate cancer	0.00304	0.027	CbGeAlD
Glycine—GCSH—prostate gland—prostate cancer	0.00294	0.026	CbGeAlD
Glycine—AGXT2—prostate gland—prostate cancer	0.0026	0.0231	CbGeAlD
Glycine—GNMT—prostate gland—prostate cancer	0.00257	0.0228	CbGeAlD
Glycine—GLDC—prostate gland—prostate cancer	0.00243	0.0216	CbGeAlD
Glycine—PIPOX—prostate gland—prostate cancer	0.00227	0.0201	CbGeAlD
Glycine—Aminocaproic Acid—AOX1—prostate cancer	0.00226	0.5	CrCbGaD
Glycine—L-Cysteine—CSAD—prostate cancer	0.00226	0.5	CrCbGaD
Glycine—GCAT—prostate gland—prostate cancer	0.0022	0.0195	CbGeAlD
Glycine—AGXT—renal system—prostate cancer	0.00209	0.0185	CbGeAlD
Glycine—GLYATL2—bone marrow—prostate cancer	0.00208	0.0185	CbGeAlD
Glycine—GCSH—renal system—prostate cancer	0.002	0.0177	CbGeAlD
Glycine—ALAS1—prostate gland—prostate cancer	0.00193	0.0171	CbGeAlD
Glycine—PIPOX—seminal vesicle—prostate cancer	0.00192	0.017	CbGeAlD
Glycine—GCAT—seminal vesicle—prostate cancer	0.00186	0.0165	CbGeAlD
Glycine—AGXT2—renal system—prostate cancer	0.00177	0.0157	CbGeAlD
Glycine—GARS—prostate gland—prostate cancer	0.00176	0.0156	CbGeAlD
Glycine—ALAS2—bone marrow—prostate cancer	0.00174	0.0155	CbGeAlD
Glycine—GLRA2—renal system—prostate cancer	0.0017	0.0151	CbGeAlD
Glycine—GATM—prostate gland—prostate cancer	0.00167	0.0148	CbGeAlD
Glycine—GLDC—renal system—prostate cancer	0.00166	0.0147	CbGeAlD
Glycine—SLC32A1—testis—prostate cancer	0.00164	0.0146	CbGeAlD
Glycine—ALAS1—seminal vesicle—prostate cancer	0.00163	0.0145	CbGeAlD
Glycine—GPR18—bone marrow—prostate cancer	0.00161	0.0143	CbGeAlD
Glycine—GRIN3B—testis—prostate cancer	0.00159	0.0141	CbGeAlD
Glycine—SLC6A9—testis—prostate cancer	0.00159	0.0141	CbGeAlD
Glycine—PIPOX—renal system—prostate cancer	0.00155	0.0137	CbGeAlD
Glycine—SHMT2—prostate gland—prostate cancer	0.00153	0.0136	CbGeAlD
Glycine—PIPOX—urethra—prostate cancer	0.00152	0.0135	CbGeAlD
Glycine—ALAS2—testis—prostate cancer	0.00149	0.0132	CbGeAlD
Glycine—GARS—seminal vesicle—prostate cancer	0.00149	0.0132	CbGeAlD
Glycine—GLRB—prostate gland—prostate cancer	0.00143	0.0127	CbGeAlD
Glycine—SHMT1—prostate gland—prostate cancer	0.00139	0.0124	CbGeAlD
Glycine—GPR18—testis—prostate cancer	0.00138	0.0122	CbGeAlD
Glycine—ALAS1—renal system—prostate cancer	0.00132	0.0117	CbGeAlD
Glycine—GCSH—testis—prostate cancer	0.00129	0.0115	CbGeAlD
Glycine—ALAS1—urethra—prostate cancer	0.00129	0.0115	CbGeAlD
Glycine—GARS—renal system—prostate cancer	0.0012	0.0106	CbGeAlD
Glycine—SLC36A1—prostate gland—prostate cancer	0.00119	0.0105	CbGeAlD
Glycine—SHMT1—seminal vesicle—prostate cancer	0.00118	0.0104	CbGeAlD
Glycine—GARS—urethra—prostate cancer	0.00118	0.0104	CbGeAlD
Glycine—SLC6A9—lymph node—prostate cancer	0.00115	0.0102	CbGeAlD
Glycine—AGXT2—testis—prostate cancer	0.00115	0.0102	CbGeAlD
Glycine—GATM—renal system—prostate cancer	0.00114	0.0101	CbGeAlD
Glycine—GCAT—bone marrow—prostate cancer	0.00114	0.0101	CbGeAlD
Glycine—GLDC—testis—prostate cancer	0.00107	0.0095	CbGeAlD
Glycine—GSS—prostate gland—prostate cancer	0.00105	0.00928	CbGeAlD
Glycine—SHMT2—renal system—prostate cancer	0.00104	0.00925	CbGeAlD
Glycine—PIPOX—testis—prostate cancer	0.001	0.00887	CbGeAlD
Glycine—GPR18—lymph node—prostate cancer	0.001	0.00887	CbGeAlD
Glycine—ALAS1—bone marrow—prostate cancer	0.000995	0.00883	CbGeAlD
Glycine—GCAT—testis—prostate cancer	0.00097	0.00861	CbGeAlD
Glycine—SHMT1—renal system—prostate cancer	0.000949	0.00842	CbGeAlD
Glycine—GCSH—lymph node—prostate cancer	0.000937	0.00831	CbGeAlD
Glycine—SHMT1—urethra—prostate cancer	0.000932	0.00827	CbGeAlD
Glycine—GARS—bone marrow—prostate cancer	0.000906	0.00804	CbGeAlD
Glycine—GSS—seminal vesicle—prostate cancer	0.000884	0.00785	CbGeAlD
Glycine—ALAS1—testis—prostate cancer	0.00085	0.00754	CbGeAlD
Glycine—SHMT1—Podofilox—Etoposide—prostate cancer	0.000835	0.222	CbGdCrCtD
Glycine—SLC36A1—renal system—prostate cancer	0.00081	0.00718	CbGeAlD
Glycine—SHMT2—bone marrow—prostate cancer	0.000788	0.00699	CbGeAlD
Glycine—GLDC—lymph node—prostate cancer	0.000777	0.00689	CbGeAlD
Glycine—GARS—testis—prostate cancer	0.000775	0.00687	CbGeAlD
Glycine—SLC16A10—prostate gland—prostate cancer	0.000766	0.00679	CbGeAlD
Glycine—GRIN2C—testis—prostate cancer	0.000762	0.00676	CbGeAlD
Glycine—ALAS1—Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.000737	0.196	CbGdCrCtD
Glycine—GATM—testis—prostate cancer	0.000735	0.00652	CbGeAlD
Glycine—SHMT1—bone marrow—prostate cancer	0.000718	0.00637	CbGeAlD
Glycine—GSS—renal system—prostate cancer	0.000713	0.00632	CbGeAlD
Glycine—GCAT—lymph node—prostate cancer	0.000703	0.00624	CbGeAlD
Glycine—GSS—urethra—prostate cancer	0.0007	0.00621	CbGeAlD
Glycine—SHMT2—testis—prostate cancer	0.000674	0.00598	CbGeAlD
Glycine—ALAS1—Estradiol—Estramustine—prostate cancer	0.000627	0.166	CbGdCrCtD
Glycine—ALAS1—lymph node—prostate cancer	0.000616	0.00547	CbGeAlD
Glycine—SHMT1—testis—prostate cancer	0.000613	0.00544	CbGeAlD
Glycine—SLC36A1—bone marrow—prostate cancer	0.000612	0.00543	CbGeAlD
Glycine—SLC16A10—epithelium—prostate cancer	0.000563	0.00499	CbGeAlD
Glycine—GARS—lymph node—prostate cancer	0.000561	0.00498	CbGeAlD
Glycine—GSS—bone marrow—prostate cancer	0.000539	0.00478	CbGeAlD
Glycine—GATM—lymph node—prostate cancer	0.000533	0.00473	CbGeAlD
Glycine—Visual impairment—Bicalutamide—prostate cancer	0.000529	0.00539	CcSEcCtD
Glycine—GRIN2A—testis—prostate cancer	0.000527	0.00467	CbGeAlD
Glycine—Urinary retention—Goserelin—prostate cancer	0.000525	0.00534	CcSEcCtD
Glycine—SLC36A1—testis—prostate cancer	0.000523	0.00464	CbGeAlD
Glycine—Dehydration—Conjugated Estrogens—prostate cancer	0.000509	0.00518	CcSEcCtD
Glycine—Oedema—Estradiol valerate/Dienogest—prostate cancer	0.000508	0.00517	CcSEcCtD
Glycine—Thrombophlebitis—Estradiol—prostate cancer	0.000506	0.00515	CcSEcCtD
Glycine—Vertigo—Cabazitaxel—prostate cancer	0.000501	0.0051	CcSEcCtD
Glycine—Polyuria—Estradiol—prostate cancer	0.000498	0.00507	CcSEcCtD
Glycine—ALAS1—Estradiol—Estrone—prostate cancer	0.000498	0.132	CbGdCrCtD
Glycine—Pain—Estrone—prostate cancer	0.000497	0.00506	CcSEcCtD
Glycine—Chills—Bicalutamide—prostate cancer	0.000493	0.00501	CcSEcCtD
Glycine—SHMT2—lymph node—prostate cancer	0.000488	0.00433	CbGeAlD
Glycine—Rhinitis—Ethinyl Estradiol—prostate cancer	0.000465	0.00474	CcSEcCtD
Glycine—Angina pectoris—Goserelin—prostate cancer	0.000465	0.00473	CcSEcCtD
Glycine—Back pain—Bicalutamide—prostate cancer	0.000462	0.00471	CcSEcCtD
Glycine—Urticaria—Estrone—prostate cancer	0.000462	0.0047	CcSEcCtD
Glycine—Pain—Nilutamide—prostate cancer	0.000462	0.0047	CcSEcCtD
Glycine—Visual disturbance—Estradiol—prostate cancer	0.000462	0.0047	CcSEcCtD
Glycine—GSS—testis—prostate cancer	0.000461	0.00409	CbGeAlD
Glycine—GLRB—lymph node—prostate cancer	0.000458	0.00406	CbGeAlD
Glycine—Oedema—Cabazitaxel—prostate cancer	0.000455	0.00463	CcSEcCtD
Glycine—Hypotension—Degarelix—prostate cancer	0.000451	0.00459	CcSEcCtD
Glycine—Visual impairment—Ethinyl Estradiol—prostate cancer	0.000447	0.00455	CcSEcCtD
Glycine—SHMT1—lymph node—prostate cancer	0.000445	0.00394	CbGeAlD
Glycine—Tachycardia—Cabazitaxel—prostate cancer	0.000444	0.00452	CcSEcCtD
Glycine—ALAS1—Estradiol—Conjugated Estrogens—prostate cancer	0.000438	0.116	CbGdCrCtD
Glycine—Pain—Estradiol valerate/Dienogest—prostate cancer	0.000434	0.00442	CcSEcCtD
Glycine—Hypotension—Cabazitaxel—prostate cancer	0.000425	0.00432	CcSEcCtD
Glycine—Diarrhoea—Estramustine—prostate cancer	0.000417	0.00424	CcSEcCtD
Glycine—Pain—Degarelix—prostate cancer	0.000413	0.0042	CcSEcCtD
Glycine—Hyponatraemia—Mitoxantrone—prostate cancer	0.000409	0.00417	CcSEcCtD
Glycine—Diarrhoea—Abiraterone—prostate cancer	0.000405	0.00412	CcSEcCtD
Glycine—Urticaria—Estradiol valerate/Dienogest—prostate cancer	0.000403	0.00411	CcSEcCtD
Glycine—Back pain—Ethinyl Estradiol—prostate cancer	0.000391	0.00398	CcSEcCtD
Glycine—Oedema—Bicalutamide—prostate cancer	0.00039	0.00397	CcSEcCtD
Glycine—Pain—Cabazitaxel—prostate cancer	0.000389	0.00396	CcSEcCtD
Glycine—Vomiting—Estramustine—prostate cancer	0.000387	0.00394	CcSEcCtD
Glycine—Dizziness—Estrone—prostate cancer	0.000385	0.00392	CcSEcCtD
Glycine—Urticaria—Degarelix—prostate cancer	0.000383	0.0039	CcSEcCtD
Glycine—Rhinitis—Goserelin—prostate cancer	0.000383	0.0039	CcSEcCtD
Glycine—SLC36A1—lymph node—prostate cancer	0.000379	0.00336	CbGeAlD
Glycine—Rhinitis—Conjugated Estrogens—prostate cancer	0.000379	0.00386	CcSEcCtD
Glycine—Dehydration—Mitoxantrone—prostate cancer	0.000379	0.00386	CcSEcCtD
Glycine—Vomiting—Abiraterone—prostate cancer	0.000376	0.00383	CcSEcCtD
Glycine—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.000374	0.00381	CcSEcCtD
Glycine—Lung disorder—Epirubicin—prostate cancer	0.00037	0.00377	CcSEcCtD
Glycine—Vomiting—Estrone—prostate cancer	0.00037	0.00376	CcSEcCtD
Glycine—Diarrhoea—Nilutamide—prostate cancer	0.00037	0.00376	CcSEcCtD
Glycine—ALAS1—Estradiol—Ethinyl Estradiol—prostate cancer	0.000368	0.0978	CbGdCrCtD
Glycine—Diarrhoea—Flutamide—prostate cancer	0.000368	0.00375	CcSEcCtD
Glycine—Visual impairment—Conjugated Estrogens—prostate cancer	0.000365	0.00371	CcSEcCtD
Glycine—Nausea—Estramustine—prostate cancer	0.000362	0.00368	CcSEcCtD
Glycine—Dizziness—Nilutamide—prostate cancer	0.000357	0.00364	CcSEcCtD
Glycine—Dizziness—Flutamide—prostate cancer	0.000356	0.00362	CcSEcCtD
Glycine—Hypersensitivity—Degarelix—prostate cancer	0.000356	0.00362	CcSEcCtD
Glycine—Lightheadedness—Docetaxel—prostate cancer	0.000347	0.00354	CcSEcCtD
Glycine—Nausea—Estrone—prostate cancer	0.000346	0.00352	CcSEcCtD
Glycine—Vomiting—Nilutamide—prostate cancer	0.000344	0.0035	CcSEcCtD
Glycine—Chills—Goserelin—prostate cancer	0.000343	0.00349	CcSEcCtD
Glycine—Lung disorder—Doxorubicin—prostate cancer	0.000342	0.00349	CcSEcCtD
Glycine—Vomiting—Flutamide—prostate cancer	0.000342	0.00348	CcSEcCtD
Glycine—SLC16A10—testis—prostate cancer	0.000337	0.00299	CbGeAlD
Glycine—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000336	0.00342	CcSEcCtD
Glycine—Hypersensitivity—Cabazitaxel—prostate cancer	0.000335	0.00341	CcSEcCtD
Glycine—GSS—lymph node—prostate cancer	0.000334	0.00296	CbGeAlD
Glycine—Pain—Bicalutamide—prostate cancer	0.000334	0.0034	CcSEcCtD
Glycine—Diarrhoea—Degarelix—prostate cancer	0.00033	0.00336	CcSEcCtD
Glycine—Oedema—Ethinyl Estradiol—prostate cancer	0.00033	0.00336	CcSEcCtD
Glycine—Thrombophlebitis—Docetaxel—prostate cancer	0.000326	0.00331	CcSEcCtD
Glycine—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000323	0.00329	CcSEcCtD
Glycine—Back pain—Goserelin—prostate cancer	0.000322	0.00327	CcSEcCtD
Glycine—Nausea—Nilutamide—prostate cancer	0.000321	0.00327	CcSEcCtD
Glycine—Nausea—Flutamide—prostate cancer	0.000319	0.00325	CcSEcCtD
Glycine—Dizziness—Degarelix—prostate cancer	0.000319	0.00325	CcSEcCtD
Glycine—Back pain—Conjugated Estrogens—prostate cancer	0.000319	0.00324	CcSEcCtD
Glycine—Thrombophlebitis—Capecitabine—prostate cancer	0.000315	0.00321	CcSEcCtD
Glycine—Vision blurred—Goserelin—prostate cancer	0.000313	0.00319	CcSEcCtD
Glycine—Diarrhoea—Cabazitaxel—prostate cancer	0.000311	0.00317	CcSEcCtD
Glycine—Polyuria—Capecitabine—prostate cancer	0.000311	0.00316	CcSEcCtD
Glycine—Vision blurred—Conjugated Estrogens—prostate cancer	0.00031	0.00316	CcSEcCtD
Glycine—Urticaria—Bicalutamide—prostate cancer	0.00031	0.00315	CcSEcCtD
Glycine—Vomiting—Degarelix—prostate cancer	0.000307	0.00312	CcSEcCtD
Glycine—Rhinitis—Estradiol—prostate cancer	0.000304	0.00309	CcSEcCtD
Glycine—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000302	0.00307	CcSEcCtD
Glycine—Dizziness—Cabazitaxel—prostate cancer	0.000301	0.00306	CcSEcCtD
Glycine—Cardiovascular disorder—Epirubicin—prostate cancer	0.000298	0.00303	CcSEcCtD
Glycine—Visual disturbance—Docetaxel—prostate cancer	0.000297	0.00303	CcSEcCtD
Glycine—Vertigo—Conjugated Estrogens—prostate cancer	0.000296	0.00301	CcSEcCtD
Glycine—Visual impairment—Estradiol—prostate cancer	0.000292	0.00297	CcSEcCtD
Glycine—Vomiting—Cabazitaxel—prostate cancer	0.000289	0.00294	CcSEcCtD
Glycine—Convulsion—Goserelin—prostate cancer	0.000288	0.00293	CcSEcCtD
Glycine—Hypersensitivity—Bicalutamide—prostate cancer	0.000287	0.00293	CcSEcCtD
Glycine—Thirst—Capecitabine—prostate cancer	0.000287	0.00292	CcSEcCtD
Glycine—Nausea—Degarelix—prostate cancer	0.000287	0.00292	CcSEcCtD
Glycine—Convulsion—Conjugated Estrogens—prostate cancer	0.000285	0.0029	CcSEcCtD
Glycine—Hyponatraemia—Docetaxel—prostate cancer	0.000283	0.00288	CcSEcCtD
Glycine—Rhinitis—Mitoxantrone—prostate cancer	0.000283	0.00288	CcSEcCtD
Glycine—Thrombophlebitis—Prednisone—prostate cancer	0.000281	0.00286	CcSEcCtD
Glycine—Cardiovascular disorder—Doxorubicin—prostate cancer	0.000276	0.00281	CcSEcCtD
Glycine—Hyponatraemia—Capecitabine—prostate cancer	0.000274	0.00279	CcSEcCtD
Glycine—Chills—Estradiol—prostate cancer	0.000272	0.00277	CcSEcCtD
Glycine—Oedema—Goserelin—prostate cancer	0.000271	0.00276	CcSEcCtD
Glycine—Nausea—Cabazitaxel—prostate cancer	0.00027	0.00275	CcSEcCtD
Glycine—Oedema—Conjugated Estrogens—prostate cancer	0.000269	0.00274	CcSEcCtD
Glycine—Diarrhoea—Bicalutamide—prostate cancer	0.000267	0.00272	CcSEcCtD
Glycine—Tachycardia—Goserelin—prostate cancer	0.000265	0.0027	CcSEcCtD
Glycine—Tachycardia—Conjugated Estrogens—prostate cancer	0.000262	0.00267	CcSEcCtD
Glycine—Dehydration—Docetaxel—prostate cancer	0.000262	0.00267	CcSEcCtD
Glycine—Urticaria—Ethinyl Estradiol—prostate cancer	0.000262	0.00267	CcSEcCtD
Glycine—Urinary retention—Capecitabine—prostate cancer	0.000259	0.00264	CcSEcCtD
Glycine—Dizziness—Bicalutamide—prostate cancer	0.000258	0.00263	CcSEcCtD
Glycine—Back pain—Estradiol—prostate cancer	0.000255	0.0026	CcSEcCtD
Glycine—Salivary hypersecretion—Epirubicin—prostate cancer	0.000254	0.00259	CcSEcCtD
Glycine—Dehydration—Capecitabine—prostate cancer	0.000254	0.00258	CcSEcCtD
Glycine—Hypotension—Goserelin—prostate cancer	0.000254	0.00258	CcSEcCtD
Glycine—Chills—Mitoxantrone—prostate cancer	0.000253	0.00258	CcSEcCtD
Glycine—Hypotension—Conjugated Estrogens—prostate cancer	0.000251	0.00256	CcSEcCtD
Glycine—Vomiting—Bicalutamide—prostate cancer	0.000248	0.00252	CcSEcCtD
Glycine—SLC16A10—lymph node—prostate cancer	0.000245	0.00217	CbGeAlD
Glycine—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000243	0.00247	CcSEcCtD
Glycine—Coma—Epirubicin—prostate cancer	0.000239	0.00244	CcSEcCtD
Glycine—Back pain—Mitoxantrone—prostate cancer	0.000238	0.00242	CcSEcCtD
Glycine—Angina pectoris—Docetaxel—prostate cancer	0.000237	0.00242	CcSEcCtD
Glycine—Vertigo—Estradiol—prostate cancer	0.000237	0.00241	CcSEcCtD
Glycine—Salivary hypersecretion—Doxorubicin—prostate cancer	0.000235	0.0024	CcSEcCtD
Glycine—Pain—Goserelin—prostate cancer	0.000232	0.00236	CcSEcCtD
Glycine—Nausea—Bicalutamide—prostate cancer	0.000232	0.00236	CcSEcCtD
Glycine—Vision blurred—Mitoxantrone—prostate cancer	0.000231	0.00236	CcSEcCtD
Glycine—Pain—Conjugated Estrogens—prostate cancer	0.00023	0.00234	CcSEcCtD
Glycine—Angina pectoris—Capecitabine—prostate cancer	0.00023	0.00234	CcSEcCtD
Glycine—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000226	0.0023	CcSEcCtD
Glycine—Coma—Doxorubicin—prostate cancer	0.000221	0.00225	CcSEcCtD
Glycine—Thrombophlebitis—Epirubicin—prostate cancer	0.00022	0.00224	CcSEcCtD
Glycine—Dizziness—Ethinyl Estradiol—prostate cancer	0.000218	0.00222	CcSEcCtD
Glycine—Urticaria—Goserelin—prostate cancer	0.000216	0.00219	CcSEcCtD
Glycine—Oedema—Estradiol—prostate cancer	0.000215	0.00219	CcSEcCtD
Glycine—Urticaria—Conjugated Estrogens—prostate cancer	0.000213	0.00217	CcSEcCtD
Glycine—Convulsion—Mitoxantrone—prostate cancer	0.000213	0.00217	CcSEcCtD
Glycine—Chills—Etoposide—prostate cancer	0.000211	0.00214	CcSEcCtD
Glycine—Tachycardia—Estradiol—prostate cancer	0.00021	0.00214	CcSEcCtD
Glycine—Vomiting—Ethinyl Estradiol—prostate cancer	0.00021	0.00213	CcSEcCtD
Glycine—Thrombophlebitis—Doxorubicin—prostate cancer	0.000203	0.00207	CcSEcCtD
Glycine—Oedema—Mitoxantrone—prostate cancer	0.0002	0.00204	CcSEcCtD
Glycine—Hypersensitivity—Goserelin—prostate cancer	0.0002	0.00203	CcSEcCtD
Glycine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000198	0.00202	CcSEcCtD
Glycine—Back pain—Etoposide—prostate cancer	0.000198	0.00201	CcSEcCtD
Glycine—Nausea—Ethinyl Estradiol—prostate cancer	0.000196	0.00199	CcSEcCtD
Glycine—Tachycardia—Mitoxantrone—prostate cancer	0.000196	0.00199	CcSEcCtD
Glycine—Rhinitis—Docetaxel—prostate cancer	0.000195	0.00199	CcSEcCtD
Glycine—Hyponatraemia—Epirubicin—prostate cancer	0.000191	0.00194	CcSEcCtD
Glycine—Rhinitis—Capecitabine—prostate cancer	0.000189	0.00193	CcSEcCtD
Glycine—Visual impairment—Docetaxel—prostate cancer	0.000188	0.00191	CcSEcCtD
Glycine—Hypotension—Mitoxantrone—prostate cancer	0.000187	0.00191	CcSEcCtD
Glycine—Diarrhoea—Goserelin—prostate cancer	0.000186	0.00189	CcSEcCtD
Glycine—Pain—Estradiol—prostate cancer	0.000184	0.00187	CcSEcCtD
Glycine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000184	0.00187	CcSEcCtD
Glycine—Vertigo—Etoposide—prostate cancer	0.000184	0.00187	CcSEcCtD
Glycine—Visual impairment—Capecitabine—prostate cancer	0.000182	0.00185	CcSEcCtD
Glycine—Dizziness—Goserelin—prostate cancer	0.000179	0.00183	CcSEcCtD
Glycine—Dizziness—Conjugated Estrogens—prostate cancer	0.000178	0.00181	CcSEcCtD
Glycine—Convulsion—Etoposide—prostate cancer	0.000177	0.0018	CcSEcCtD
Glycine—Dehydration—Epirubicin—prostate cancer	0.000177	0.0018	CcSEcCtD
Glycine—Hyponatraemia—Doxorubicin—prostate cancer	0.000177	0.0018	CcSEcCtD
Glycine—Chills—Docetaxel—prostate cancer	0.000175	0.00178	CcSEcCtD
Glycine—Vomiting—Goserelin—prostate cancer	0.000173	0.00176	CcSEcCtD
Glycine—Pain—Mitoxantrone—prostate cancer	0.000171	0.00174	CcSEcCtD
Glycine—Vomiting—Conjugated Estrogens—prostate cancer	0.000171	0.00174	CcSEcCtD
Glycine—Urticaria—Estradiol—prostate cancer	0.000171	0.00174	CcSEcCtD
Glycine—Chills—Capecitabine—prostate cancer	0.000169	0.00172	CcSEcCtD
Glycine—Back pain—Docetaxel—prostate cancer	0.000164	0.00167	CcSEcCtD
Glycine—Dehydration—Doxorubicin—prostate cancer	0.000164	0.00167	CcSEcCtD
Glycine—Tachycardia—Etoposide—prostate cancer	0.000163	0.00166	CcSEcCtD
Glycine—Nausea—Goserelin—prostate cancer	0.000161	0.00164	CcSEcCtD
Glycine—Angina pectoris—Epirubicin—prostate cancer	0.00016	0.00163	CcSEcCtD
Glycine—Nausea—Conjugated Estrogens—prostate cancer	0.00016	0.00163	CcSEcCtD
Glycine—Urticaria—Mitoxantrone—prostate cancer	0.000159	0.00162	CcSEcCtD
Glycine—Back pain—Capecitabine—prostate cancer	0.000159	0.00162	CcSEcCtD
Glycine—Hypersensitivity—Estradiol—prostate cancer	0.000158	0.00161	CcSEcCtD
Glycine—Hypotension—Etoposide—prostate cancer	0.000156	0.00159	CcSEcCtD
Glycine—Vision blurred—Capecitabine—prostate cancer	0.000155	0.00158	CcSEcCtD
Glycine—Angina pectoris—Doxorubicin—prostate cancer	0.000148	0.00151	CcSEcCtD
Glycine—Vertigo—Capecitabine—prostate cancer	0.000148	0.0015	CcSEcCtD
Glycine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000148	0.0015	CcSEcCtD
Glycine—Diarrhoea—Estradiol—prostate cancer	0.000147	0.0015	CcSEcCtD
Glycine—Convulsion—Docetaxel—prostate cancer	0.000147	0.0015	CcSEcCtD
Glycine—Pain—Etoposide—prostate cancer	0.000143	0.00145	CcSEcCtD
Glycine—Dizziness—Estradiol—prostate cancer	0.000142	0.00145	CcSEcCtD
Glycine—Oedema—Docetaxel—prostate cancer	0.000139	0.00141	CcSEcCtD
Glycine—Vision blurred—Prednisone—prostate cancer	0.000138	0.0014	CcSEcCtD
Glycine—Diarrhoea—Mitoxantrone—prostate cancer	0.000137	0.0014	CcSEcCtD
Glycine—Vomiting—Estradiol—prostate cancer	0.000137	0.00139	CcSEcCtD
Glycine—Tachycardia—Docetaxel—prostate cancer	0.000135	0.00138	CcSEcCtD
Glycine—Oedema—Capecitabine—prostate cancer	0.000134	0.00137	CcSEcCtD
Glycine—Urticaria—Etoposide—prostate cancer	0.000132	0.00135	CcSEcCtD
Glycine—Rhinitis—Epirubicin—prostate cancer	0.000132	0.00134	CcSEcCtD
Glycine—Vertigo—Prednisone—prostate cancer	0.000132	0.00134	CcSEcCtD
Glycine—Tachycardia—Capecitabine—prostate cancer	0.000131	0.00133	CcSEcCtD
Glycine—Hypotension—Docetaxel—prostate cancer	0.000129	0.00132	CcSEcCtD
Glycine—Nausea—Estradiol—prostate cancer	0.000128	0.0013	CcSEcCtD
Glycine—Vomiting—Mitoxantrone—prostate cancer	0.000127	0.0013	CcSEcCtD
Glycine—Convulsion—Prednisone—prostate cancer	0.000127	0.00129	CcSEcCtD
Glycine—Visual impairment—Epirubicin—prostate cancer	0.000127	0.00129	CcSEcCtD
Glycine—Hypotension—Capecitabine—prostate cancer	0.000125	0.00128	CcSEcCtD
Glycine—Hypersensitivity—Etoposide—prostate cancer	0.000123	0.00125	CcSEcCtD
Glycine—Rhinitis—Doxorubicin—prostate cancer	0.000122	0.00124	CcSEcCtD
Glycine—Oedema—Prednisone—prostate cancer	0.000119	0.00122	CcSEcCtD
Glycine—Nausea—Mitoxantrone—prostate cancer	0.000119	0.00121	CcSEcCtD
Glycine—Pain—Docetaxel—prostate cancer	0.000118	0.00121	CcSEcCtD
Glycine—Chills—Epirubicin—prostate cancer	0.000118	0.0012	CcSEcCtD
Glycine—ALAS1—Budesonide—Prednisone—prostate cancer	0.000118	0.0313	CbGdCrCtD
Glycine—Visual impairment—Doxorubicin—prostate cancer	0.000117	0.00119	CcSEcCtD
Glycine—Tachycardia—Prednisone—prostate cancer	0.000117	0.00119	CcSEcCtD
Glycine—Pain—Capecitabine—prostate cancer	0.000115	0.00117	CcSEcCtD
Glycine—Diarrhoea—Etoposide—prostate cancer	0.000114	0.00116	CcSEcCtD
Glycine—Back pain—Epirubicin—prostate cancer	0.000111	0.00113	CcSEcCtD
Glycine—Dizziness—Etoposide—prostate cancer	0.00011	0.00112	CcSEcCtD
Glycine—Chills—Doxorubicin—prostate cancer	0.000109	0.00111	CcSEcCtD
Glycine—Vision blurred—Epirubicin—prostate cancer	0.000108	0.0011	CcSEcCtD
Glycine—Urticaria—Capecitabine—prostate cancer	0.000107	0.00108	CcSEcCtD
Glycine—Vomiting—Etoposide—prostate cancer	0.000106	0.00108	CcSEcCtD
Glycine—Vertigo—Epirubicin—prostate cancer	0.000103	0.00105	CcSEcCtD
Glycine—Back pain—Doxorubicin—prostate cancer	0.000102	0.00104	CcSEcCtD
Glycine—Hypersensitivity—Docetaxel—prostate cancer	0.000102	0.00104	CcSEcCtD
Glycine—Vision blurred—Doxorubicin—prostate cancer	9.98e-05	0.00102	CcSEcCtD
Glycine—Convulsion—Epirubicin—prostate cancer	9.92e-05	0.00101	CcSEcCtD
Glycine—Nausea—Etoposide—prostate cancer	9.9e-05	0.00101	CcSEcCtD
Glycine—Hypersensitivity—Capecitabine—prostate cancer	9.88e-05	0.00101	CcSEcCtD
Glycine—Vertigo—Doxorubicin—prostate cancer	9.52e-05	0.000969	CcSEcCtD
Glycine—Urticaria—Prednisone—prostate cancer	9.49e-05	0.000966	CcSEcCtD
Glycine—Diarrhoea—Docetaxel—prostate cancer	9.48e-05	0.000965	CcSEcCtD
Glycine—Oedema—Epirubicin—prostate cancer	9.34e-05	0.000951	CcSEcCtD
Glycine—Convulsion—Doxorubicin—prostate cancer	9.18e-05	0.000934	CcSEcCtD
Glycine—Diarrhoea—Capecitabine—prostate cancer	9.18e-05	0.000934	CcSEcCtD
Glycine—Dizziness—Docetaxel—prostate cancer	9.16e-05	0.000933	CcSEcCtD
Glycine—Tachycardia—Epirubicin—prostate cancer	9.12e-05	0.000928	CcSEcCtD
Glycine—Dizziness—Capecitabine—prostate cancer	8.87e-05	0.000903	CcSEcCtD
Glycine—Vomiting—Docetaxel—prostate cancer	8.81e-05	0.000897	CcSEcCtD
Glycine—Hypersensitivity—Prednisone—prostate cancer	8.8e-05	0.000896	CcSEcCtD
Glycine—Hypotension—Epirubicin—prostate cancer	8.73e-05	0.000889	CcSEcCtD
Glycine—Oedema—Doxorubicin—prostate cancer	8.65e-05	0.00088	CcSEcCtD
Glycine—Vomiting—Capecitabine—prostate cancer	8.53e-05	0.000868	CcSEcCtD
Glycine—Tachycardia—Doxorubicin—prostate cancer	8.44e-05	0.000859	CcSEcCtD
Glycine—Nausea—Docetaxel—prostate cancer	8.23e-05	0.000838	CcSEcCtD
Glycine—Diarrhoea—Prednisone—prostate cancer	8.17e-05	0.000832	CcSEcCtD
Glycine—Hypotension—Doxorubicin—prostate cancer	8.08e-05	0.000822	CcSEcCtD
Glycine—Pain—Epirubicin—prostate cancer	7.99e-05	0.000813	CcSEcCtD
Glycine—Nausea—Capecitabine—prostate cancer	7.97e-05	0.000811	CcSEcCtD
Glycine—Dizziness—Prednisone—prostate cancer	7.9e-05	0.000804	CcSEcCtD
Glycine—Vomiting—Prednisone—prostate cancer	7.6e-05	0.000773	CcSEcCtD
Glycine—Urticaria—Epirubicin—prostate cancer	7.42e-05	0.000756	CcSEcCtD
Glycine—Pain—Doxorubicin—prostate cancer	7.39e-05	0.000753	CcSEcCtD
Glycine—ALAS1—Dexamethasone—Prednisone—prostate cancer	7.2e-05	0.0191	CbGdCrCtD
Glycine—ALAS1—Betamethasone—Prednisone—prostate cancer	7.2e-05	0.0191	CbGdCrCtD
Glycine—Nausea—Prednisone—prostate cancer	7.1e-05	0.000722	CcSEcCtD
Glycine—Hypersensitivity—Epirubicin—prostate cancer	6.88e-05	0.000701	CcSEcCtD
Glycine—Urticaria—Doxorubicin—prostate cancer	6.87e-05	0.000699	CcSEcCtD
Glycine—Diarrhoea—Epirubicin—prostate cancer	6.39e-05	0.000651	CcSEcCtD
Glycine—Hypersensitivity—Doxorubicin—prostate cancer	6.37e-05	0.000648	CcSEcCtD
Glycine—Dizziness—Epirubicin—prostate cancer	6.18e-05	0.000629	CcSEcCtD
Glycine—Vomiting—Epirubicin—prostate cancer	5.94e-05	0.000605	CcSEcCtD
Glycine—Diarrhoea—Doxorubicin—prostate cancer	5.92e-05	0.000602	CcSEcCtD
Glycine—Dizziness—Doxorubicin—prostate cancer	5.72e-05	0.000582	CcSEcCtD
Glycine—Nausea—Epirubicin—prostate cancer	5.55e-05	0.000565	CcSEcCtD
Glycine—Vomiting—Doxorubicin—prostate cancer	5.5e-05	0.00056	CcSEcCtD
Glycine—Nausea—Doxorubicin—prostate cancer	5.14e-05	0.000523	CcSEcCtD
Glycine—AGXT2—Metabolism—TYMS—prostate cancer	8.11e-06	3.82e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP3A4—prostate cancer	8.1e-06	3.82e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—MTHFR—prostate cancer	8.07e-06	3.8e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GSTM1—prostate cancer	8.01e-06	3.78e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP1B1—prostate cancer	7.96e-06	3.75e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GGT1—prostate cancer	7.91e-06	3.73e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PPARA—prostate cancer	7.91e-06	3.73e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—LPL—prostate cancer	7.87e-06	3.71e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CG—prostate cancer	7.85e-06	3.7e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HIF1A—prostate cancer	7.81e-06	3.68e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—NCOA1—prostate cancer	7.8e-06	3.67e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—INS—prostate cancer	7.79e-06	3.67e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—INS—prostate cancer	7.79e-06	3.67e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—INS—prostate cancer	7.79e-06	3.67e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—INS—prostate cancer	7.79e-06	3.67e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GGT1—prostate cancer	7.71e-06	3.64e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—MYC—prostate cancer	7.69e-06	3.62e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—CAV1—prostate cancer	7.68e-06	3.62e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP19A1—prostate cancer	7.68e-06	3.62e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—LPL—prostate cancer	7.66e-06	3.61e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CREBBP—prostate cancer	7.63e-06	3.6e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CREBBP—prostate cancer	7.63e-06	3.6e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—CREBBP—prostate cancer	7.63e-06	3.6e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CREBBP—prostate cancer	7.63e-06	3.6e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—LEP—prostate cancer	7.63e-06	3.59e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CYP1A1—prostate cancer	7.6e-06	3.58e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—NCOA1—prostate cancer	7.6e-06	3.58e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PDGFRB—prostate cancer	7.59e-06	3.58e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CAV1—prostate cancer	7.56e-06	3.56e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ERCC2—prostate cancer	7.53e-06	3.55e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP19A1—prostate cancer	7.49e-06	3.53e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KDR—prostate cancer	7.47e-06	3.52e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CAV1—prostate cancer	7.44e-06	3.51e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—INS—prostate cancer	7.43e-06	3.5e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—RXRA—prostate cancer	7.42e-06	3.49e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—ERCC2—prostate cancer	7.33e-06	3.46e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ESR1—prostate cancer	7.28e-06	3.43e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—CREBBP—prostate cancer	7.28e-06	3.43e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CD—prostate cancer	7.24e-06	3.41e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CD—prostate cancer	7.24e-06	3.41e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CD—prostate cancer	7.24e-06	3.41e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CD—prostate cancer	7.24e-06	3.41e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—RXRA—prostate cancer	7.23e-06	3.41e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTEN—prostate cancer	7.19e-06	3.39e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—ERBB3—prostate cancer	7.17e-06	3.38e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FGFR2—prostate cancer	7.16e-06	3.38e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—COMT—prostate cancer	7.14e-06	3.37e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTP1—prostate cancer	7.11e-06	3.35e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.11e-06	3.35e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—BAD—prostate cancer	7.11e-06	3.35e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—MTHFR—prostate cancer	7.08e-06	3.34e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CG—prostate cancer	7e-06	3.3e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ITPR1—prostate cancer	7e-06	3.3e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—COMT—prostate cancer	6.96e-06	3.28e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PPARA—prostate cancer	6.95e-06	3.27e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTP1—prostate cancer	6.93e-06	3.27e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CD—prostate cancer	6.9e-06	3.25e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MTHFR—prostate cancer	6.89e-06	3.25e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APC—prostate cancer	6.88e-06	3.24e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CG—prostate cancer	6.88e-06	3.24e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—TERT—prostate cancer	6.88e-06	3.24e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—EP300—prostate cancer	6.86e-06	3.23e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—PPARA—prostate cancer	6.83e-06	3.22e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—NOS3—prostate cancer	6.83e-06	3.22e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—NOS3—prostate cancer	6.83e-06	3.22e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—NOS3—prostate cancer	6.83e-06	3.22e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—NOS3—prostate cancer	6.83e-06	3.22e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ITPR1—prostate cancer	6.82e-06	3.21e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IRS1—prostate cancer	6.8e-06	3.21e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGF—prostate cancer	6.8e-06	3.21e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CG—prostate cancer	6.78e-06	3.19e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—INS—prostate cancer	6.62e-06	3.12e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—TYMS—prostate cancer	6.61e-06	3.11e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—GSK3B—prostate cancer	6.6e-06	3.11e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HIF1A—prostate cancer	6.57e-06	3.1e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CAV1—prostate cancer	6.53e-06	3.08e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTM1—prostate cancer	6.53e-06	3.08e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—NOS3—prostate cancer	6.52e-06	3.07e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—INS—prostate cancer	6.51e-06	3.07e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—CREBBP—prostate cancer	6.49e-06	3.06e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—TYMS—prostate cancer	6.44e-06	3.04e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—INS—prostate cancer	6.42e-06	3.02e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—LPL—prostate cancer	6.41e-06	3.02e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CREBBP—prostate cancer	6.38e-06	3.01e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTM1—prostate cancer	6.37e-06	3e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CAV1—prostate cancer	6.36e-06	3e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CB—prostate cancer	6.31e-06	2.97e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CB—prostate cancer	6.31e-06	2.97e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CB—prostate cancer	6.31e-06	2.97e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CB—prostate cancer	6.31e-06	2.97e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IGF1—prostate cancer	6.3e-06	2.97e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CREBBP—prostate cancer	6.28e-06	2.96e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—EGFR—prostate cancer	6.27e-06	2.96e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—LPL—prostate cancer	6.25e-06	2.95e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PTGS2—prostate cancer	6.25e-06	2.95e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTGS2—prostate cancer	6.25e-06	2.95e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTGS2—prostate cancer	6.25e-06	2.95e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTGS2—prostate cancer	6.25e-06	2.95e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP1A1—prostate cancer	6.19e-06	2.92e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CD—prostate cancer	6.15e-06	2.9e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ERCC2—prostate cancer	6.14e-06	2.89e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAP2K1—prostate cancer	6.09e-06	2.87e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CD—prostate cancer	6.05e-06	2.85e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP1A1—prostate cancer	6.04e-06	2.84e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CB—prostate cancer	6.02e-06	2.84e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PIK3CA—prostate cancer	5.99e-06	2.82e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ERCC2—prostate cancer	5.99e-06	2.82e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SERPINE1—prostate cancer	5.98e-06	2.82e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—BAD—prostate cancer	5.98e-06	2.82e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTGS2—prostate cancer	5.96e-06	2.81e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CD—prostate cancer	5.96e-06	2.81e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CG—prostate cancer	5.95e-06	2.8e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—KRAS—prostate cancer	5.92e-06	2.79e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—NOS3—prostate cancer	5.81e-06	2.74e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FGF2—prostate cancer	5.79e-06	2.73e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—APC—prostate cancer	5.79e-06	2.73e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—MTHFR—prostate cancer	5.77e-06	2.72e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—EGF—prostate cancer	5.73e-06	2.7e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IRS1—prostate cancer	5.73e-06	2.7e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NOS3—prostate cancer	5.71e-06	2.69e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPARA—prostate cancer	5.66e-06	2.67e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—INS—prostate cancer	5.63e-06	2.65e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—MTHFR—prostate cancer	5.63e-06	2.65e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—NOS3—prostate cancer	5.63e-06	2.65e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—GSK3B—prostate cancer	5.56e-06	2.62e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—JAK2—prostate cancer	5.55e-06	2.62e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PPARA—prostate cancer	5.52e-06	2.6e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CREBBP—prostate cancer	5.52e-06	2.6e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—INS—prostate cancer	5.48e-06	2.58e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTEN—prostate cancer	5.45e-06	2.57e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTEN—prostate cancer	5.45e-06	2.57e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PTEN—prostate cancer	5.45e-06	2.57e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTEN—prostate cancer	5.45e-06	2.57e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CA—prostate cancer	5.44e-06	2.56e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.43e-06	2.56e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MDM2—prostate cancer	5.42e-06	2.55e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CREBBP—prostate cancer	5.37e-06	2.53e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CB—prostate cancer	5.36e-06	2.53e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ERBB2—prostate cancer	5.34e-06	2.52e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—AKT1—prostate cancer	5.33e-06	2.51e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CAV1—prostate cancer	5.33e-06	2.51e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTGS2—prostate cancer	5.31e-06	2.5e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CB—prostate cancer	5.27e-06	2.49e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CD—prostate cancer	5.23e-06	2.47e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTEN—prostate cancer	5.2e-06	2.45e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—EP300—prostate cancer	5.2e-06	2.45e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—EP300—prostate cancer	5.2e-06	2.45e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—EP300—prostate cancer	5.2e-06	2.45e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—EP300—prostate cancer	5.2e-06	2.45e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CB—prostate cancer	5.19e-06	2.45e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CAV1—prostate cancer	5.19e-06	2.45e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTGS2—prostate cancer	5.15e-06	2.43e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MAP2K1—prostate cancer	5.13e-06	2.42e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CD—prostate cancer	5.09e-06	2.4e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CA—prostate cancer	5.07e-06	2.39e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCL8—prostate cancer	5.07e-06	2.39e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—SERPINE1—prostate cancer	5.04e-06	2.37e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—EP300—prostate cancer	4.96e-06	2.34e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN1B—prostate cancer	4.95e-06	2.33e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—NOS3—prostate cancer	4.94e-06	2.33e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—AKT1—prostate cancer	4.9e-06	2.31e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FGF2—prostate cancer	4.88e-06	2.3e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CG—prostate cancer	4.85e-06	2.29e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CASP3—prostate cancer	4.85e-06	2.29e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL2—prostate cancer	4.84e-06	2.28e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL6—prostate cancer	4.82e-06	2.27e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NOS3—prostate cancer	4.81e-06	2.27e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CG—prostate cancer	4.73e-06	2.23e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCND1—prostate cancer	4.72e-06	2.23e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CTNNB1—prostate cancer	4.68e-06	2.2e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—JAK2—prostate cancer	4.67e-06	2.2e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTEN—prostate cancer	4.63e-06	2.18e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—INS—prostate cancer	4.59e-06	2.16e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MMP9—prostate cancer	4.58e-06	2.16e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN1A—prostate cancer	4.57e-06	2.15e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MDM2—prostate cancer	4.56e-06	2.15e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CB—prostate cancer	4.56e-06	2.15e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PTEN—prostate cancer	4.56e-06	2.15e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTGS2—prostate cancer	4.52e-06	2.13e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CREBBP—prostate cancer	4.5e-06	2.12e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—ERBB2—prostate cancer	4.5e-06	2.12e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTEN—prostate cancer	4.49e-06	2.12e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—INS—prostate cancer	4.47e-06	2.11e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—AKT1—prostate cancer	4.45e-06	2.1e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CB—prostate cancer	4.44e-06	2.09e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—EP300—prostate cancer	4.42e-06	2.08e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTGS2—prostate cancer	4.4e-06	2.07e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CREBBP—prostate cancer	4.38e-06	2.07e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EP300—prostate cancer	4.35e-06	2.05e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—EP300—prostate cancer	4.28e-06	2.02e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CD—prostate cancer	4.26e-06	2.01e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SRC—prostate cancer	4.23e-06	1.99e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN1B—prostate cancer	4.17e-06	1.96e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CD—prostate cancer	4.16e-06	1.96e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—AKT1—prostate cancer	4.14e-06	1.95e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VEGFA—prostate cancer	4.12e-06	1.94e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—STAT3—prostate cancer	4.08e-06	1.92e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—NOS3—prostate cancer	4.03e-06	1.9e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTEN—prostate cancer	3.94e-06	1.86e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CTNNB1—prostate cancer	3.94e-06	1.85e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—NOS3—prostate cancer	3.92e-06	1.85e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CA—prostate cancer	3.84e-06	1.81e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CA—prostate cancer	3.84e-06	1.81e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CA—prostate cancer	3.84e-06	1.81e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CA—prostate cancer	3.84e-06	1.81e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN1A—prostate cancer	3.84e-06	1.81e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTEN—prostate cancer	3.84e-06	1.81e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MYC—prostate cancer	3.79e-06	1.78e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TGFB1—prostate cancer	3.78e-06	1.78e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—EP300—prostate cancer	3.76e-06	1.77e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CB—prostate cancer	3.72e-06	1.75e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGFR—prostate cancer	3.7e-06	1.75e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTGS2—prostate cancer	3.68e-06	1.74e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CA—prostate cancer	3.67e-06	1.73e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—EP300—prostate cancer	3.66e-06	1.72e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CB—prostate cancer	3.62e-06	1.71e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTGS2—prostate cancer	3.59e-06	1.69e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—SRC—prostate cancer	3.56e-06	1.68e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KRAS—prostate cancer	3.5e-06	1.65e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—STAT3—prostate cancer	3.43e-06	1.62e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CA—prostate cancer	3.27e-06	1.54e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CA—prostate cancer	3.21e-06	1.52e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTEN—prostate cancer	3.21e-06	1.51e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MYC—prostate cancer	3.19e-06	1.5e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—TGFB1—prostate cancer	3.18e-06	1.5e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CA—prostate cancer	3.17e-06	1.49e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—AKT1—prostate cancer	3.14e-06	1.48e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AKT1—prostate cancer	3.14e-06	1.48e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AKT1—prostate cancer	3.14e-06	1.48e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AKT1—prostate cancer	3.14e-06	1.48e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTEN—prostate cancer	3.13e-06	1.48e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—EGFR—prostate cancer	3.12e-06	1.47e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—prostate cancer	3.11e-06	1.47e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—EP300—prostate cancer	3.06e-06	1.44e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—AKT1—prostate cancer	3e-06	1.41e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—EP300—prostate cancer	2.99e-06	1.41e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—KRAS—prostate cancer	2.95e-06	1.39e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6—prostate cancer	2.85e-06	1.34e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CA—prostate cancer	2.78e-06	1.31e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CA—prostate cancer	2.71e-06	1.28e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKT1—prostate cancer	2.67e-06	1.26e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT1—prostate cancer	2.63e-06	1.24e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKT1—prostate cancer	2.59e-06	1.22e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6—prostate cancer	2.4e-06	1.13e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AKT1—prostate cancer	2.27e-06	1.07e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CA—prostate cancer	2.27e-06	1.07e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT1—prostate cancer	2.21e-06	1.04e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CA—prostate cancer	2.21e-06	1.04e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKT1—prostate cancer	1.85e-06	8.72e-06	CbGpPWpGaD
Glycine—GSS—Metabolism—AKT1—prostate cancer	1.8e-06	8.5e-06	CbGpPWpGaD
